SCHEMBL13762202

SCHEMBL13762202

CC(C)(C)c1cccc(C(=O)NCC2CCCCN2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN9A Q15858 1/20 0.54
▸ PARP1 P09874 1/20 0.52
▸ HDAC6 Q9UBN7 3/20 0.48
▸ HDAC4 P56524 1/20 0.48
▸ ROCK2 O75116 2/20 0.47
▸ ROCK1 Q13464 1/20 0.47
▸ CYP1A2 P05177 2/20 0.46
▸ CYP2D6 P10635 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ CACNA1F O60840 1/20 0.46
▸ KCNA5 P22460 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ ADRA1A P35348 1/20 0.46
▸ OPRK1 P41145 1/20 0.46
▸ CACNA1D Q01668 1/20 0.46
▸ KCNH2 Q12809 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13762194 0.87 SCN9A (0.62) SCN9AHDAC6HDAC4CYP1A2CYP2D6
SCHEMBL17886781 0.83 SCN9A (0.57) SCN9AHDAC6HDAC4LMNASMN1; SMN2
SCHEMBL13766311 0.82 PARP1 (0.61) SCN9APARP1HDAC6HDAC4ROCK2
SCHEMBL20344071 0.82 CYP1A2 (0.58) SCN9APARP1HDAC6HDAC4ROCK2
SCHEMBL3760743 0.81 ADRB1 (0.59) SCN9APARP1HDAC6HDAC4CYP1A2
SCHEMBL6221703 0.81 ADRB1 (0.59) SCN9APARP1HDAC6HDAC4CYP1A2
SCHEMBL279575 0.81 HPGD (0.59) SCN9APARP1HDAC6ROCK2ROCK1
SCHEMBL8288130 0.79 ALDH1A1 (0.53) SCN9APARP1ROCK2ROCK1SMN1; SMN2
SCHEMBL10380819 0.79 ROCK2 (0.58) SCN9APARP1ROCK2ROCK1MEN1
SCHEMBL5088410 0.77 ADRB1 (0.60) SCN9APARP1HDAC6HDAC4ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7557110-B2 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine TEIJIN PHARMA LIMITED (JP) 2009-07-07 — — US disclosed
Send feedback